• Tesla (TSLA) has increased Optimus production roughly tenfold in recent months, according to supply-chain reports, but the robot's hands and forearms remain a critical bottleneck.
  • The company is auditing Chinese suppliers to ensure quality and production-line compliance as it prepares for a broader ramp.
  • Tesla's Q2 2026 results show mounting pressure on profitability, with operating margin falling to 1.4% and free cash flow negative $1.092 billion, making Optimus a high-stakes bet.

A Tenfold Increase, With Caveats

Tesla has ramped up production of its Optimus humanoid robot roughly tenfold in recent months, according to people familiar with the supply chain, signaling a shift from a difficult redesign phase into a renewed manufacturing push. However, the figure is based on supplier activity and not a verified unit-production disclosure from Tesla itself.

The central challenge remains the robot's hands and forearms. Building a dexterous, durable, and manufacturable hand has proven substantially harder than demonstrating a prototype. Earlier setbacks, including a reported halt in assembly in 2025 due to hand-design problems, forced Tesla to scale back its original target of at least 5,000 robots by the end of 2025 to about 2,000, according to reports. Partially completed bodies awaited hands and forearms, highlighting the complexity of the task.

Supply Chain Audits in China

By September 2026, Tesla teams were reportedly auditing suppliers in China's Yangtze River Delta, including Tuopu Group (601689.SS), Sanhua Intelligent Controls (002050.SZ), and Joyson Electronics, after several had already received Optimus orders. The audits focus on quality and production-line compliance, and production is slated to begin once suppliers pass. This move underscores Tesla's reliance on established high-volume manufacturing capabilities in China, but it also exposes the program to geopolitical risks, tariffs, and export controls.

The robot entering this phase is described as third-generation Optimus, featuring redesigned dexterous hands and joint actuators. Initial applications are expected to be bounded industrial jobs such as materials handling and basic assembly-line assistance, rather than broad general-purpose labor. Tesla itself has confirmed a more cautious version of the story: it decommissioned Model S and Model X lines at its Fremont factory to install first-generation Optimus production lines. Initial builds will go to an "Optimus Academy" for training-data collection and further development. Tesla said production was anticipated in 2026 but did not report a verified production count in its Q2 filing.

Financial Strains and Strategic Importance

Optimus is strategically important for Tesla as it attempts to expand from electric vehicles and energy storage into AI-enabled automation. But the project comes amid financial strain. Tesla's Q2 2026 results showed revenue rose 26% year over year to $28.236 billion, yet GAAP operating income plummeted 57% to $398 million, and operating margin fell to 1.4% from 4.1%. Capital expenditure surged 142% to $5.789 billion, driving free cash flow to negative $1.092 billion, down from positive $146 million a year earlier. The company ended the quarter with $43.524 billion in cash and short-term investments, giving it the balance-sheet capacity to fund an early robotics ramp, but the heavy spending on AI, factories, and battery infrastructure is pressuring near-term profitability.

"What institutional investors like us are really focused on is regulatory stability," said a person familiar with Tesla's investor communications, speaking on condition of anonymity. "But for Tesla, the question is whether Optimus can become a material revenue contributor before cash reserves dwindle." Tesla did not respond to a request for comment on the production figures.

Implications for Suppliers and Workers

The ramp-up could create new demand for precision structural parts, actuators, joint modules, sensors, motors, and transmission components. However, capacity planning should not be confused with revenue: supplier audit activity and component orders do not establish that Tesla can produce, deploy, or sell robots at scale.

For workers, humanoid robots may reduce exposure to repetitive or hazardous tasks, but they also raise concerns about job displacement and workplace surveillance. The public debate is not only whether Optimus can walk or manipulate objects, but whether it can perform useful work safely, for long periods, at a cost that beats human labor or specialized automation. Regulators will likely intensify scrutiny of workplace safety, machine autonomy, and liability as deployment expands.

What to Watch

Over the next several quarters, the most meaningful markers will be evidence that the hand redesign has solved durability and manufacturability problems, confirmation that suppliers pass audits, and Tesla's disclosure of actual production and deployment metrics—not just planned capacity. The company's official language remains measured: initial Optimus units are for data collection and functionality development, with first-generation production lines being installed for 2026. That framing supports the view that the next phase is an engineering-validation ramp rather than full commercial scale.

The upside case is substantial: if Tesla can produce reliable humanoids at automotive-like scale and use its AI stack to improve capability continuously, it could create a new automation platform. The downside case is that dexterous manipulation, battery endurance, and safety validation remain harder than expected, leaving Optimus a costly research-and-development project for longer than investors anticipate. For now, the tenfold production increase is a sign of progress, but the hand remains the wild card.